Lowering Costs Through Effective Hematologic Malignancy Diagnosis

Supplements


Optimal management of hematologic malignancies requires an early, accurate, complete, and clear diagnosis. Hematologic malignancies, however, are frequently misdiagnosed. Studies have demonstrated misdiagnosis in up to 27% of leukemia, 18% of lymphoma, and 75% of Burkitt lymphoma cases.

Download PDF
Last modified: August 30, 2021
Copyright © The Lynx Group, LLC. All rights reserved.